Gothenburg, Sweden

Dag Selander

This inventor holds 2 USPTO granted patents. Top assignees: Astra Ab, Astrazeneca Ab. Active years: 2002-2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dag Selander. Retrieved from https://idiyas.com/inventor/dag-selander

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2002-2003

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Dag Selander: Innovator in Pain Management

Introduction

Dag Selander is a notable inventor based in Göteborg, Sweden. He has made significant contributions to the field of pain management through his innovative inventions. With a total of 2 patents, Selander's work focuses on the medical applications of ropivacaine.

Latest Patents

Selander's latest patents revolve around the intramuscular use of ropivacaine for the manufacture of a medicament aimed at treating musculoskeletal pain, particularly myofascial pain and tendinitis. This invention highlights the potential of ropivacaine as an effective solution for pain management.

Career Highlights

Throughout his career, Dag Selander has worked with prominent companies such as Astra AB and AstraZeneca AB. His experience in these organizations has contributed to his expertise in the pharmaceutical field and his ability to innovate in pain management solutions.

Collaborations

Selander has collaborated with various professionals in his field, including Göran Isacsson. These partnerships have likely enhanced his research and development efforts.

Conclusion

Dag Selander's contributions to pain management through his patents demonstrate his commitment to improving medical treatments. His work continues to influence the field and offers hope for effective pain relief solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…